Katherine Elizabeth Talcott MD
Retinal Disease
Vitreoretinal Specialist, Cole Eye Institute, Cleveland Clinic
Join to View Full Profile
9500 Euclid AveCleveland, OH 44195
Dr. Talcott is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts Eye and Ear/Harvard Medical SchoolResidency, Ophthalmology, 2012 - 2015
Mass General Brigham/Brigham and Women's HospitalInternship, Internal Medicine, 2011 - 2012
University of California San Francisco School of MedicineClass of 2011
Certifications & Licensure
MA State Medical License 2015 - 2026
OH State Medical License 2018 - 2025
PA State Medical License 2016 - 2018
American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 2 citationsThe Effect of Semaglutide and GLP-1 RAs on Risk of Nonarteritic Anterior Ischemic Optic Neuropathy.Nadia J Abbass, Raya Nahlawi, Jacqueline K Shaia, Kevin C Allan, David C Kaelber
American Journal of Ophthalmology. 2025-06-01 - Progression, Treatment, and Outcomes of Retinal Vascular Diseases in Pregnancy.Elise Timtim, Xiangyu Ji, Romy Bejjani, Jonathan Markle, Maria Magraner
Retina. 2025-04-11 - Ocular manifestations in Ehlers-Danlos syndrome.Sonia B Kim, Jacqueline K Shaia, David C Kaelber, Rishi P Singh, Katherine E Talcott
Eye. 2025-04-10
Press Mentions
Anti-VEGF in the Real World: Who Is at Risk of Vision Loss After Lapse in Treatment?April 1st, 2025- Spotlight on Expanded Field Imaging Findings in Proliferative Sickle Cell RetinopathySeptember 1st, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
